OncologyCE
LECTURECME

Clinical Advances in Cutaneous T-cell Lymphoma: What You Need to Know About a Rare Malignancy

Author(s)/Faculty: Steven M. Horwitz, MD; Lauren Pinter-Brown, MD
Release Date: 1/7/2019Expiration Date: 1/6/2020
Credit Type: CMENumber of Credits: 0.75
Content Type: LectureProvider:
Cutaneous T-cell lymphoma (CTCL) is a rare and heterogeneous type of T-cell lymphoma that is often challenging to diagnose. Of the most common subtypes of CTCL, Sézary syndrome is generally more aggressive than mycosis fungoides and primary cutaneous peripheral T-cell lymphomas, and although most CTCLs have an indolent course, approximately 25% of patients will develop progressive disease. Treatment of CTCL can also be challenging, especially in advanced disease requiring systemic therapy. Two recently approved systemic agents for the treatment of CTCL have the potential to enhance outcomes and quality of life in affected patients. Within this live education symposium, experts in the field will review and discuss criteria for the differential diagnosis of CTCL, as well as provide guidance for the application of the latest evidence to the treatment of patients with CTCL. Presentation of a clinical case will further provide clinical pearls for the diagnosis and management of CTCL.